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Author Summary
Advances in healthcare and in the quality of life significantly increase human life expectancy. With the
ageing of populations, new un-faced challenges are brought to science. The human body is naturally
selected to be well-functioning until the age of reproduction to keep the species alive. However, as the
lifespan extends, unseen problems due to the body deterioration emerge. There are several age-related
diseases with no appropriate treatment; therefore, the complex ageing phenomena needs further under-
standing. Immunosenescence, the ageing of the immune system, is highly correlated to the negative
effects of ageing, such as the increase of auto-inflammatory diseases and decrease in responsiveness to
new diseases. Besides clinical and mathematical tools, we believe there is opportunity to further exploit
simulation tools to understand immunosenescence. Compared to real-world experimentation, benefits in-
clude time and cost effectiveness due to the laborious, resource-intensiveness of the biological environment
and the possibility of conducting experiments without ethic restrictions. Contrasted with mathematical
models, simulation modelling is more suitable for representing complex systems and emergence. In ad-
dition, there is the belief that simulation models are easier to communicate in interdisciplinary contexts.
Our work investigates the usefulness of simulations to understand immunosenescence by employing two
different simulation methods, agent-based and system dynamics simulation, to a case study of immune
cells depletion with age.
Abstract
Advances in healthcare and in the quality of life significantly increase human life expectancy. With the
ageing of populations, new un-faced challenges are brought to science. The human body is naturally
selected to be well-functioning until the age of reproduction to keep the species alive. However, as
the lifespan extends, unseen problems due to the body deterioration emerge. There are several age-
related diseases with no appropriate treatment; therefore, the complex ageing phenomena needs further
understanding. It is known that immunosenescence is highly correlated to the negative effects of ageing.
In this work we advocate the use of simulation as a tool to assist the understanding of immune ageing
phenomena. In particular, we are comparing system dynamics modelling and simulation (SDMS) and
agent-based modelling and simulation (ABMS) for the case of age-related depletion of naive T cells in
the organism. We address the following research questions: Which simulation approach is more suitable
for this problem? Can these approaches be employed interchangeably? Is there any benefit of using one
approach compared to the other? Results show that both simulation outcomes closely fit the observed
data and existing mathematical model; and the likely contribution of each of the naive T cell repertoire
maintenance method can therefore be estimated. The differences observed in the outcomes of both
approaches are due to the probabilistic character of ABMS contrasted to SDMS. However, they do not
interfere in the overall expected dynamics of the populations. In this case, therefore, they can be employed
interchangeably, with SDMS being simpler to implement and taking less computational resources.
21 Introduction
Bulati et al. [1] characterises ageing as a complex process with negative repercussion on the development
and functioning of the immune system. Progressive changes of the immune system components have a
major impact on the capacity of an individual to produce effective immune responses. The decrease of
immunocompetence in the elderly is the result of the continuous challenge and unavoidable exposure to
a variety of potential antigens [2]. Virus, bacteria, fungus, food, etc. cause persistent life-long antigenic
stress, which is responsible for the filling of the immunological space by the accumulation of effector cells
and immune memory.
Franceschi [2] also identified some factors that characterise immune system ageing, many of which
affect immune cells populations such as T cells. There is, for instance an accumulation of memory T cells
and a marked reduction of the T cell repertoire. In addition, the thymic involution after twenties has a
significant impact in the reduction of naive T cells numbers. Naive T cells are immunocompetent cells
which role is to respond to new faced antigens. The depletion of these cells therefore eventually leaves
the body more susceptible to new diseases [3].
This work is an extension of initial experiments with naive T cell populations presented in [4]. Our
objective is to study the decay of these cells numbers with age, under a simulation perspective. We
therefore compare SDMS and ABMS for an immune system ageing model involving interactions which
influence the naive T cell populations over time. The model is based on a set of ordinary differential
equations (ODEs) defined in [3]. In their work, Murray et al. [3] propose a model with a set of equations
to fit observed data and estimate the output of different naive T cells populations with age. We built
equivalent models employing SDMS and ABMS, compare results and validate our outcomes with real-
world data and the original ODE model [3]. Our objective is to answer the following research questions:
Which approach is more suitable for this problem? Can we use both approaches interchangeably? What
are the benefits and problems encountered in each approach for this problem? In order to answer our
research questions the naive depletion case study is investigated under five scenarios defined in [3]. For
each setting, the rates of changes within the cell populations are modified in order to determine how
these changes are reflected under each simulation approach.
The remainder of this paper is organised as follows. Section 1.1 presents a review on the basic concepts
of simulation, SDMS and ABMS. Section 1.2 introduces the literature concerned with the comparison of
SDMS and ABMS. In Section 2.1 we describe the system used to define our simulations. Sections 2.2
and 2.3 introduce our SDMS and ABMS, respectively. Section 2.4 describes our experimental design,
followed by the results obtained (Section 3). Section 4 presents our conclusions and opportunities for
future work.
1.1 Background
A computational simulation of a system is as a “imitation (on a computer) of a system as it progresses
through time” [5]. Its purpose is to understand, change, manage and control reality [6]. Moreover,
simulation is employed to obtain further understanding of the system and/or to identify improvements to
a system [5]. A simulation predicts the performance of a system given a specific set of inputs. According
to Robinson [5], simulation is an experimental approach to modelling a “what-if” analysis tool. The model
user determines the scenarios and the simulation predicts the outcomes. Simulation can, therefore, also
be seen as a decision support tool. Compared to real-world experimentation, simulation is generally
more cost-effective and less time consuming. Furthermore, under a controlled simulation environment,
changes and different scenarios are analysed without impact to the real-world [5], requiring no ethical
agreements. The choice of the appropriate simulation method [4, 7, 8] will determine the efficacy of
the decision tool for a certain problem. In addition, different approaches impact on the content of the
information produced by the simulation. Current major system simulation modelling methods consist
of system dynamics modelling (SDM), discrete-event modelling, dynamic systems modelling and agent-
3based modelling (ABM) [9]. We however investigate SDM and ABM, as they appear to be the most
employed in immunology [10].
System Dynamics (SD) [11] is an aspect of systems theory currently applied to any complex system
characterized by interdependency, mutual interaction, information feedback and circular causality. The
basis of the SD methodology is the recognition that the structure of a system is just as important in
determining its behaviour as the individual components themselves. It is therefore necessary to adopt
a “systemic way of thinking” [12], where the focus is on the top-down, internal system structure. This
means that the problem should be depicted as a set of patterns, interrelated processes and generic
structures [13]. SD works with feedback loops, stocks and flows that describe a system’s nonlinearity.
The changes that occur over time in the variables of the problem are ruled by ordinary differential
equations. After understanding the structure of the problem to be simulated, it is necessary to translate
it into a causal loop diagram, which is a graphical representation used in SD. Causal loop diagrams aid
visualization of how interrelated variables affect one another. System Dynamics Simulation (SDS) is a
continuous simulation for an SD model. It consists of a set of ordinary differential equations that are
solved for a certain time interval [14]. The simulation, therefore, has a deterministic output.
Agent-based modelling and simulation (ABMS) is a stochastic method, which employs a set of au-
tonomous agents that interact with each other in a certain environment [15]. As it is derived from
complex systems, its baseline is the notion that systems are built in a bottom-up perspective. In other
words, an understanding of the dynamics of the system arises from individual interactions and their
environment [16]. The agents’ behaviours are described by rules that determine how they learn, interact
with each other and adapt. The overall system behaviour is given by the agents’ individual behaviours
as well as by their interactions. ABMS is therefore well suited to modelling and simulating systems
with heterogenous, autonomous and pro-active actors, such as human-centred systems, biological sys-
tems, businesses and organizations [17]. ABM can be done using state chart diagrams from the unified
modelling language (UML). With state charts it is possible to define and visualize the agents’ states,
transitions between the states, events that trigger transitions, timing and agent actions [9].
The next section introduces the literature review concerned with the comparison between SDMS and
ABMS for different problem domains. We initially review general work that has been carried out to assess
the differences of both approaches. Subsequently, we focus on research concerned with the comparison
of the strategies for immunological problems. We found, however, that there is a scarcity of literature
comparing the two approaches for immune simulation.
1.2 Related Work
Scholl [18] conducts one of the first studies characterising the domains of applicability of SDMS and
ABMS. The author also investigates the strengths and weaknesses of each approach, outlining opportu-
nities for SDMS and ABMS-based multi-method modelling. Pourdehnad et al. [19] extends this pioneer
work by comparing the two approaches conceptually. The authors discuss the potential synergy between
both paradigms to solve problems of teaching decision-making processes. Similarly, Stemate et al. [20]
compare these modelling approaches and identify a list of likely opportunities for cross-fertilization. The
authors see this list as a starting point for other researchers to take such synergistic views further.
Schieritz [21] and Scheritz et al. [22] contribute largely to the comparison of SDMS and ABMS for
operational research (OR). They identify the unique features of each approach and present a table with
their main differences. Further in [23] the authors describe an approach to combine ODEs and ABMS for
solving supply chain management problems. Their results show that the combined SDMS/ABMS does
not produce the same outcomes as those from the SDMS alone. To understand why these differences
occur, the authors indicate that more research needs to be conducted.
Ramandad et al. [24] compare the dynamics of a ABMS and SDMS for contagious disease spread.
The authors convert the ABM into an SDM and examine the impact of individual heterogeneity and
different network topologies. They conclude that the deterministic SDMS yields a single trajectory for
4each parameter set, while the stochastic ABMS yield a distribution of outcomes. Moreover, the outcomes
differ in several metrics relevant to public health.
Schieritz [25] analyses two arguments given in literature to explain the superiority of ABMS compared
with SDMS for social simulation: (1) the inability of SD to represent emergence and (2) SD’s lack
of individual diversity. The author points out that an agent-based approach models individuals and
interactions on a lower level, implicitly taking up an individualist position of emergence; conversely, SD
models social phenomena at an aggregate level. As a second part of the study, the author compares SDM
and ABM for modelling species competing for resources to analyse the effects of evolution on population
dynamics. The conclusion is that when individual diversity is considered, it limits the applicability of
the ODE model. However, it is shown that “a highly aggregate more ODE-like model of an evolutionary
process displays similar results to the ABMS”.
Similarly, Lorenz [8] proposes three aspects to be compared for the choice between SDMS and ABMS:
structure, behaviour and emergence. Structure is related to how the model is built. The structure of a
SDMS model is static, whereas in ABMS it is dynamic. In SDMS, all the elements of the simulation are
developed in advance. In ABMS, on the other hand, agents are created or destroyed and interactions
are defined through the course of the simulation run. The second aspect (behaviour) focuses on the
central generators of behaviours in the model. For SDMS the behaviour generators are feedback and
accumulations, while for ABM they are the interactions of the systems elements. Both methodologies
incorporate feedback. ABMS, however, has feedback in more than one level of modelling. The third
aspect lies in their capacity to capture emergence, which differs between the two methodologies. In
disagreement with Schieritz [25] mentioned earlier, the author states that ABMS is capable of capturing
emergence, while the one-level structure of SDMS is insufficient in that respect.
In previous work [10] we discuss the merits of SDMS and ABMS for problems involving the interactions
with the immune system and early-stage cancer. Our interest was to identify those cases in immunology
where ABMS and SDMS could be applied interchangeably without compromising the results usefulness.
In addition, we wanted to investigate those circumstances where one approach was not able to reflect
the compared approach outcomes. We found several outcome differences: (i) not everything produced by
the SDMS can be observed in ABMS outcomes (e.g. no half agents), which can impact in the outcomes
similarity when the populations size is small (less than 50 agents); (ii) for our case studies, ABMS
contributed to additional insights; due to its stochastic nature and emergent behaviour it produced
different results and extra patterns of behaviour. In this work we continue our investigations by applying
the comparison to an immunosenescence problem, as shown next.
2 Methods
2.1 Case Study: Naive T Cells Output
Before the age of 20, the set of naive T cells is sustained primarily by the thymus [3]. Thymic contributions
in an individual are quantified by the presence of a biological marker known as ‘T cell receptors excision
circle’ (TREC), which is a circular DNA originated during the formation of the T-cell receptor. The
percentage of T cells with TRECs decays with shrinkage of thymic output, activation and reproduction
of naive T cells [3]. This means that naive T cells from the thymus have a greater percentage of TREC than
those originating from other sources. In middle age, however, the thymus involutes and there is a change
in the source of naive T cells. There is a considerable reduction in thymic naive T cell output, which
means that new naive T cells are mainly produced by existing cells reproduction (peripheral expansion).
It is believed that the naive T cell repertoire after twenties is also maintained by the population of existing
memory cells, which have their phenotype reverted back to the naive cells type [3].
These two new methods of naive T cell repertoire maintenance, however, are insufficient to keep an
effective defense system in the organism [3], as they do not produce new phenotypic changes in the T cells.
5Rather, evidence shows that they continue to fill the naive T cell space with copies of existing cells [26],
which are incapable to eliminate new antigens. The loss (death) of clones of some antigen-specific T cells
therefore becomes irreversible. These age-related phenomena lead to a decay of immune performance.
Our study on the dynamics of naive T cells over time is based on equations obtained in [3] and
real-world data from [3, 27, 28]. The model objective is to investigate the likely contribution of each of
the naive T cell’s sources by comparing estimates of the presence of TREC in the cells. In the model,
four populations are considered, naive T cells from thymus, naive T cells from peripheral proliferation,
active cells and memory cells. The mathematical model of the dynamics of the cell populations and its
sustaining sources is presented next.
2.1.1 The Mathematical Model
The model proposed in [3] is described by equations 1 to 6, in which N is the number of naive cells from
thymus, Np is the number of naive cells that have undergone proliferation, A are the active cells, M is
the number of memory cells and t is time (in years). At the beginning of life most naive T cells belong
to the population N . With time naive T cells from thymus proliferate, which contributes for the increase
of the Np population. When the body faces a new threat, naive T cells are recruited and become active
(A). A fraction of active cells turns into memory cells (M).
The first differential equation describing the naive T cell population from thymus is:
dN
dt
= s0e
−λtts(Np)− [λn + µng(Np)]N (1)
where s0 is the thymic output value, λt is the thymic decay rate, t represents time in years, s0e
−λtts(Np)
is the number of cells that arise from the thymus and s(Np) is the rate of export of the thymus defined
by:
s(Np) =
1
1 + s¯
Np
N¯p
(2)
N¯p and s¯ are equilibrium and scaling values respectively. These values were established in [3]. λnN
represents the naive cells that become part of the naive proliferating population, λn is the naive prolif-
eration rate, µn is the thymic naive cells death rate, µng(Np)N represents the naive cell death rate and
g(Np) is the death rate between naive TREC-positive and naive TREC-negative cells, defined as:
g(Np) = 1 +
bNp
N¯p
1 +
Np
N¯p
(3)
The second differential equation describing the naive T cells from proliferation is:
dNp
dt
= λnN + [ch(N,Np)− µn]Np + λmnM (4)
where c is the proliferation rate, ch(N,Np)Np represents the naive proliferation and h(N,Np) is the
dilution of thymic-naive through proliferation defined by:
h(N,Np) =
1
1 +
N+Np
N¯p
(5)
µnNp is the death rate of proliferation-originated naive cells and λmn is the reversion rate from
memory into Np.
The final differential equation for the memory cell population dynamics is:
6dM
dt
= λaA− µmM − λmnM (6)
where λa is the reversion rate into memory and µm is the death rate of memory cells.
The parameter values for the model are shown in Table 1. For the mathematical model and subsequent
simulations, s0 = 56615. The values for active cells over time are determined by referring to data collected
by [29] (Figure 1). This table contains the number of activated CD4+ cells (a type of naive T cells) per
mm3 for early years and is used as a stock for the active cells. From the active cell stock the values of
the memory cell stock are updated according to the parameter λa.
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Figure 1. The data set used as a look-up table for the active cells
Equations 1 to 6 are incorporated in the SDM and ABM in order to investigate if it is possible to
reproduce and validate the results obtained in [3]. Moreover, variations of the ratio variables are explored
to understand the importance of each individual integrand in the system. For example, it is important
to establish how much the proliferation rate impacts on the depletion of naive T cells over age, and to
identify the point in time at which the system can be defined as losing functionality.
2.2 The System Dynamics Modelling and Simulation
The SD’s model stock and flow diagram is constituted by the stocks, flows, information, auxiliaries and
parameters, as shown in Figure 2. In the model, the naive T cells, naive T cells from proliferation and
memory cells are the stock variables, as the aim is to keep information of how they accumulate over time.
In the figure, the stock variable that represents the number of naive T cells (Naive) is subject to
inflowing thymic output (ThymusOutput), and proliferation (NaiveCellsInProliferation) and death
(NaiveDeath) outflows. The stock of naive cells from proliferation’s (NaiveProliferation) inflows are
proliferation and reversion from memory (MemoryToNaiveProliferation), and the outflow is death,
according to Equation 2. The memory stock’s inflow is reversion from active (ReversionToMemory).
The outflows are reversion to a naive phenotype (in the figure, MemoryToNaiveProliferation and death,
7Figure 2. The system dynamics model, functions and parameters
as defined by Equation 6). The number of active cells, which is a stock, is given by real-world data of
active cells in the human organism (in the figure, it is the table RealActives).
Information (curved arrows in the stock and flow diagram) between stocks and flows indicates that
there is an information about a stock that influences a flow. By looking at Equation 1, it is possible to
determine that there is information between the stock Naive (N in Equation 1) and the flowNaiveDeath.
For the NaiveProliferation stock there is information from it to Proliferation and Death flows. In the
Memory stock there is information from it to the flowsMemoryToNaiveProliferation andMemoryDeath.
The model parameters are the same as those in the mathematical model.
For our implementation, functions are designed for s and g, which use the stock NaiveProliferation
in their calculations. Hence, the information about NaiveProliferation is implicit in these functions.
The mathematical parameters and their correspondents in the SD model are shown in Table 2.
Table 3 demonstrates the flows for each stock, their correspondent in the mathematical model and the
flow formula. In the table, the functions s0(), s(), g() and h() are implemented according to corresponding
mathematical functions. The function time() returns the current simulation time, which, for this case,
is given in years. Furthermore, the ThymusOuput is an example of flow which does not have any
information or parameter. Hence, it is defined according to the mathematical expression stated.
2.3 The Agent-based Modelling and Simulation
In our model T cells are the agents, which can assume three states: Naive, NaiveFromProliferation
and Memory, as shown in the state chart depicted in Figure 3. The lozenge in the top of the state chart
represents a branch for the decision of the T cell current state. In the figure, there are also final states
when cells die and are eliminated from the system (represented by a black circle outlined with a smaller
filled in circle inside it). Each agent behaviour depends on its current state and occurs according to a
certain parameter rate. The agent’s parameters and behaviours corresponding to each state are shown
in Table 4.
8Figure 3. The naive T cell agent
The agents’ transitions (arrows) determine the changes in states. The state changes and death rates
are given by the ratios defined in the mathematical model. Initially, all the agents are in the naive state.
As the simulation proceeds, they can assume other stages according to the transition pathways defined
in the state chart.
When agents reproduce, the newborn agents, which are also T cells, should assume the same state
as their original agent. Apart from proliferation, new agents are also produced from thymic output and
reversion from active to memory cells. The algorithm that determines the agent state is given according
to the flow chart in Figure 4.
Figure 4. New agent (T cell) state decision flow chart
Our agents respond to changes in time and do not interact with each other directly. For the simulation
9development, apart from the agents, there is also a function that determines the thymic output and the
number of active cells (from the look-up table) that become memory cells. Both are implemented using
events that determine when each of these T cells should enter the system. The thymic output calculation,
the functions s, g, h and the active cells look-up table are the same as those from the SD model.
2.4 Experiments
Five simulation scenarios were studied, defined by [3] with different values for the parameters. A summary
of parameters changed for each scenario is illustrated in Table 5.
The first scenario investigates whether there is the need for naive peripheral proliferation throughout
life to sustain the naive population. The naive peripheral proliferation rate for this experiment is therefore
set to zero. It also considers reversion from memory to a naive phenotype.
The second scenario assumes peripheral proliferation with a higher rate of naive cells becoming naive
proliferating cells (λn = 2.1). There is no reversion from memory to a naive phenotype and no homeostatic
reduction in thymic export. The functions s, g and h from the mathematical model are responsible for
controlling the thymic export, naive death rate and naive peripheral proliferation respectively. In order
to alter the thymic export, the parameters s and Np are changed. The parameter b is set to zero so that
the function g remains constant during the entire simulation, as does the death rate of naive cells.
The third scenario alters the function g over time by setting the parameter b greater than zero
(b = 4.2). This means that the death rate of naive T cells from thymus increases along the years as
the number of naive from peripheral proliferations rises. There is no change to the thymic export, no
reversion from memory to a naive phenotype and the conversion rate of naive from thymus to naive
proliferation is low (equal to 0.003).
Scenario 4 intends to produce the opposite results from those of scenario 3. In this case there is no
change in the death rate of naive T cells from thymus. Rather, there is change on the thymic export with
time.
Finally, the fifth scenario presents no restrictions, which means that there are changes in thymic
export and death of naive cells over time. Moreover, there is peripheral proliferation and no memory
turns back to a naive phenotype.
Two datasets were used for validation of the simulations. They are displayed in Tables 6 (obtained
from [3] and [27]) and 7 (obtained from [28]). The datasets contain information about the TREC marker
in individuals grouped in age ranges. In the tables, the first column shows the age range of the individuals;
the second column has the mean log10 TREC106 PBMC (peripheral blood mononuclear cell) and the third
column contains the number of individuals in each age range.
The diagram containing the TREC data (naive from thymus) and total naive cell data provided
by [3] [27] and [28] is shown in Figure 5. In the figure, data provided in Table 6 is represented by the
symbol © ; the  symbol indicates the data from Table 7. In addition, the total percentage of naive T
cells in the body, obtained in [3], is also displayed (symbol ♦).
Each simulation was run for a period of one hundred years taking into account the impact of thymic
shrinkage per mm3 of peripheral blood and 3673 initial naive cells from thymus. For the ABM, the
simulation was run fifty times and the mean result of these runs was collected.
3 Results
The simulation results contrasting SDMS with ABMS are illustrated in Figures 6, 7 and 8. Figures 6(a),
7(a) and 8(a) show the ODE results used as a baseline for our results validation. Overall, when comparing
SDMS and ABMS outputs, the results were similar. As expected, the ABMS produced some variation
on the simulation curves while SDMS’s curve was steady. In addition, SDMS took far less computational
resources.
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Figure 5. Data sets (collected in [3], [27] and [28]) used for validation of the naive T cell output
simulation models
In the first scenario, the results for both simulation techniques show a very similar trend curve,
although the ABMS results exhibit a more noisy behaviour in time. Results did not fit the original
data (Tables 6 and 7). We believe, however that the ABMS results can be improved to match the data
more closely. We employed the same laws and rates from the original ODE model, which is one of the
shortcomings of our work. We intend in the future to calibrate the ABMS solely with the data provided
and observe the changes in the outcome.
Regarding the biological dynamics, naive cells from thymus curve demonstrated a substantial decay in
thymic export on the beginning of life because of the high death rate. After the twenties, an exponential
decay of thymic export was observed and the dynamics followed the thymic decay rate rule defined in the
mathematical model. The naive proliferation curve increased with the decrease of naive from thymus,
but as there was no proliferation of peripheral cells, they died with no replacement. Thus they followed
the same pattern as that of their only source, i.e. thymic naive cells. The results indicate that peripheral
proliferation is important for maintenance of naive T cells.
Results from scenario 2 matched the original data more closely for both approaches. This case
considered peripheral proliferation, as well as a high rate of naive cells from the thymus turning into
peripheral naive cells. The naive from thymus curve shows a substantial decay in the beginning of
life because of the death and proliferation rates. On the other hand, the naive from proliferation curve
increased with the decrease of the naive from thymus curve. The main difference between these results and
the results from the previous scenario is that the number of naive cells from proliferation reached a stable
value after the age of twenty with no further decay. The results indicate the importance of peripheral
expansion, but also the need for a smaller rate of naive to peripheral naive conversion. Moreover, reversion
from memory to a naive phenotype does not seem to influence the overall quantities of cells.
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Figure 6. Results for naive T cells from thymus
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Figure 7. Results for naive T cells from peripheral proliferation
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Figure 8. Results for total T cells
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Scenario 3 took into account the results produced in the previous scenarios and adjusted the param-
eters in a way that a more accurate output was obtained. The naive from thymus curve presented a
decay at the beginning of life followed by an interval of stability. By the age of twenty the thymic export
decreased in an exponential trend. With the decay of naive from thymus, the naive repertoire changed
from the thymic source to peripheral proliferation source. By performing these simulations it is therefore
possible to have an idea of how the decay of naive cells occurs over time. The results now closely matched
the original data. Scenarios 4 and 5 produced similar results to scenario 3. This indicates that alterations
in thymic export and in naive death do not interfere significantly with the overall dynamics of the naive
T cells.
In the five scenarios studied, the simulations produced similar results for both SDMS and ABMS. This
can also be observed in the results of Wilcoxon rank sum tests applied to both ABMS and SDMS results
(Table 8). The table reports p-values associated with Wilcoxon rank sum tests for the five scenarios. Our
hypothesis is that the outcomes produced are not significantly different. The p-values for each test all
exceed the 0.05 (5%) significance level, indicating that the distributions of the outcomes of the various
simulation approaches are not statistically different and therefore, the tests failed to reject the similarity
hypothesis.
4 Discussion
Besides mathematics, simulation becomes more and more popular in immunology research; however,
comparisons of different simulation methods in this field are very rare. In this research we contrasted
two different simulation methods, SDMS and ABMS, for an immunosenescence case study and tested if
they provided us with a different insight. Our simulation models were based on mathematical equations
describing thymic decay and nave cells dynamics converted into SDMS and ABMS. Five simulation
scenarios were studied investigating different sustaining sources for the naive cell population. Our research
questions were: Which simulation approach is more suitable for this problem? Can these approaches be
employed interchangeably? Is there any benefit of using one approach compared to the other?
Results for both methods matched those from the original ODE model. In the ABMS simulation, cells
were subject to individual rates that occurred during the time slot in which they were created. However,
this did not seem to have interfered in the final outcome. Further, as our experiments involved large
populations, the variability inherent in ABMS did not considerably affect the overall dynamics of the
simulated population. In the SDMS simulation outputs were exactly the same as those from the ODEs,
as expected. The SDMS was simpler to implement and required significantly less computational resources
such as memory, processing time and complexity. Therefore, although in this work both approaches can
be employed interchangeably, SDMS seems more suitable.
The SDM and ABM were built based on the initial mathematical rules used to fit of the data collected,
which is a limitation of our work. This induces the output of the simulations to behave similarly to that
from the ODE model. The new results therefore were no more informative than the original ODE model,
as they fit the data in the same manner. Furthermore, incorporating the functions for thymus output, g,
s and h to the ABM made it hybrid; and its stochastic character did not produce any significant variant
(extreme pattern) of the expected outcomes. Emergence was also not observed.
Another relevant aspect is that the agents considered are static (no movement) and non-interacting,
which was a limitation imposed by the way the biological system was described. The features of the
problem studied therefore did not allow us to exploit the ABMS capabilities appropriately.
The advantage of applying SDM and ABM to this case study is therefore mostly due to the fact that
the modelling processes are more intuitive than the original ODE model. Additionally, the diagrams of
both SDM and ABM are easier to communicate in multidisciplinary contexts. In particular, due to the
characteristics of the problem, SDM also appears to be more suitable for the modelling process. We believe
therefore that the value of employing simulation in this case study context is in model communication to
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non-experts. Our future goal is to find ways to formalise the translation from ODE to SDM and ABM
and to find out which of these is actually preferred by practitioners.
As another future aim, to overcome our modelling and simulation shortcomings it is our intention to
rebuilt and calibrate our models based solely on the data provided. We intend to assess and report on
the impacts of this procedure. We hypothesize that changes in the SDMS and ABMS can show further
differences in the results. In addition, we believe we can achieve a better representation of the biological
phenomena and therefore better fitting of the data. We intend to subsequently validate our modelling
efforts with imunologists. This should help enforcing the idea regarding the usefulness of SDM and ABM
simulations to understand immunosenescence, contrasted to the traditional mathematical modelling.
Acknowledgements
We would like to thank Dr. Alice R. Lorenzi and Professor John D. Isaacs for providing us one of the
data sets for our experiments. We would also like to thank Dr. John Murray and D. D. Ho for access to
their data set and help with this work.
References
1. Bulatti M, Pellican M, Vasto S, Colonna-Romano G (2008) Understanding ageing: Biomedical and
bioengineering approaches, the immunologic view. Immunity & Ageing 5.
2. Franceschi C, Bonaf M, Valensin S (2000) Human immonosenescence: the prevailing of innate
immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18:
1717-1720.
3. Murray JM, Kaufmann GR, Hodgkin PD, Lewin SR, Kelleher AD, et al. (2003) Naive T cells are
maintained by thymic output in early ages but by proliferation without phenotypic change after
twenty. Immunology and Cell Biology 81: 487-495.
4. Figueredo GP, Aickelin U (2010) Investigating immune system aging: System dynamics and agent-
based modelling. In: Proceedings of the Summer Computer Simulation Conference 2010.
5. Robinson S (2004) Simulation: The Practice of Model Development and Use. John Wiley and
sons, Ltd.
6. Pidd M (2003) Tools for thinking: Modelling in management science. Wiley. Chichester, UK.
7. Barton P, Brian S, Robinson S (2004) Modelling in the economic evaluation of health care: selecting
the appropriate approach. Journal of Health Services Research and Policy 9: 110-118.
8. Lorenz T (2009) Abductive fallacies with agent-based modelling and system dynamics. Epistemo-
logical Aspects of Computer Simulation in the Social Sciences 5466: 141-152.
9. Borshchev A, Filippov A (2004) From system dynamics and discrete event to practical agent based
modeling: Reasons, techniques, tools. In: Proceedings of the XXII International Conference of the
System Dynamics society.
10. Figueredo GP (2012) Translating Simulation Approaches for Immunology. Ph.D. thesis, School of
Computer Science, The University of Nottingham.
11. Forrester JW (1958) Industrial dynamics–a major breakthrough for decision makers. Harvard
Business Review 36: 37-66.
16
12. Kirkwood CW (1998) System Dynamics Methods: A Quick Introduction.
13. Richardson GP, Pugh AL (1981) Introduction of System Dynamics Modelling with DYNAMO.
MIT Press, Cambridge, MA, USA.
14. Macal CM (2010) To agent-based simulation from system dynamics. In: Proceedings of the 2010
Winter Simulation Conference.
15. Wooldridge M (2002) An Introduction to Multiagent Systems. John Wiley and Sons Inc, England.
16. C M Macal MJN (2010) Tutorial on agent-based modelling and simulation. Journal of Simulation
4: 151-162.
17. Siebers PO, Aickelin U (2007) Encyclopaedia of Decision Making and decision support technologies,
chapter Introduction to Multi-Agent Simulation. pp. 554-564.
18. Scholl HJ (2001) Agent-based and system dynamics modeling: a call for cross study and joint
research. In: Proceedings of the 34th Annual Hawaii International Conference on Systems Sciences.
19. Pourdehnad J, Maani K, Sedehi H (2002) System dynamics and intelligent agent based simulation:
where is the synergy? In: Proceedings of the XX International Conference of the System Dynamics
society.
20. Stemate L, Taylor I, Pasca C (2007) A comparison between system dynamics and agent based
modeling and opportunities for cross-fertilization. In: Proceedings of the 2007 Winter Simulation
Conference. S. G. Henderson, B. Biller, M.-H. Hsieh, J. Shortle, J. D. Tew, and R. R. Barton.
21. Schieritz N (2002) Integrating system dynamics and agent-based modeling. In: Proceedings of the
XX International Conference of the System Dynamics society.
22. Schieritz N, Milling PM (2003) Modeling the forrest or modeling the trees: A comparison of system
dynamics and agent based simulation. In: Proceedings of the XXI International Conference of the
System Dynamics society.
23. Schieritz N, Gro¨βler A (2003) Emergent structures in supply chains: a study integrating agent-
based and system dynamics modeling. In: Proceedings of the XXI International Conference of the
System Dynamics society.
24. Ramandad H, Sterman J (2008) Heterogeneity and network structure in the dynamics of diffusion:
Comparing agent-based and differential equation models. Management Science 5.
25. Schieritz N (2004) Exploring the agent vocabulary – emergency and evolution in system dynamics.
In: Proceedings of the 2004 system dynamics conference.
26. Martinis MD, Franceschi C, Monti D, Ginaldi L (2005) Inflamm-ageing and lifelong antigenic load
as major determinants of ageing rate and longevity. FEBS 579: 2035-2039.
27. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, et al. (1996) CD45 isoforms expression
on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T
cell memory. Mechanisms of Ageing and Development 86: 173 - 195.
28. Lorenzi A, Patterson A, Pratt A, Jefferson M, CE Chapman and F Ponchel JI (2008) Determination
of thymic function directly from peripheral blood: A validated modification to an established
method. Journal of Immunological Methods 389: 185-194.
29. Comans-Bitter WM, de Groot R, van den Beemd R (1997) Immunophenotyping of blood lympho-
cytes in childhood. reference values for lymphocites subpopulations. J Pediatr : 388-393.
17
Figure Legends
Figure 1. The data set used as a look-up table for the active cells. The data set contains the
number of activated CD4 cells per mm3 for early years taken from Comans-Bitter et al. [29].
Figure 2. The system dynamics model, functions and parameters. The table function
RealActives returns the values for active T cells at a certain time. The functions h, g and s correspond
to the functions defined in the mathematical model. In the diagram the round squares are the stocks,
the grey straight arrows with an hourglass are the flows, the curved arrows are the information used to
determine stock and flow values, the grey circles are constant values and the grey circles with a triangle
inside are the variables or parameters of the system.
Figure 3. The naive T cell agent. In the state-chart diagram the round squares represent the
states, the arrows are the transitions, the black circles outlined with a smaller filled in circle inside it are
the final states (death), the lozenge represents a decision of the initial state of the agent and the circles
with a small triangle inside are the variables of the system.
Figure 5. Data sets (collected in [3], [27] and [28]) used for validation of the naive T cell
output simulation models. In the figure, the original values were converted to percentage.
Tables
Table 1. Rate values for the mathematical model (obtained from [3])
rate value(s)
λt
log(2)
15.7 (year
−1)
λn 0.22, 2.1, 0.003
µn 4.4
c 0 (no proliferation) or µn(1 +
300
N¯p
)
λmn 0
µm 0.05
λa 1
Table 2. Parameters from the mathematical model and their correspondents from the SD model
rate correspondent
s0 s0
λt lambda t
c c
Np bar Np
s bar s
b n
λn ProliferationRate
µn NaiveDeathRate
λmn MemoryToNPRate
µNp NPDeathRate
µm MemoryDeathRate
λa ReversionToMemoryRate
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Table 3. Flow calculations for the naive T cell output model
Stock Flow Expression Flow formula
Naive
ThymusOutput s0e
−λtts(Np) s0()e
−λt.time()s()
NaiveCellsInProliferation λnN ProliferationRate.Naive
NaiveDeath µng(Np)N (NaiveDeathRate.
g()Naive)
NaiveProliferation
Proliferation ch(N,Np) (c× h().
NaiveProliferation)
Death µnNp (NpDeathRate.
NaiveProliferation)
Memory
MemoryToNaiveProlife− λmnM (MemoryToNPRate.
ration Memory)
ReversionToMemory λaA (ReversionToMemoryRate.
RealActives(time()))
MemoryDeath µmM (MemoryDeathRate.
Memory)
Table 4. Agents’ parameters and behaviours for the naive T cell output model
State Parameters Reactive behaviour Proactive behaviour
Naive
NaiveDeathRate Dies
Is produced
by thymus
ProliferationRate Reproduces
NaiveProliferation
NaiveProliferationDeathRate Dies
ProliferationRate Is produced by
Naive proliferation
MemoryToNPRate Is produced from
Memory
NaiveProliferationRate Reproduces
Memory
MemoryDeathRate Dies
ReversionToMemoryRate Is produced from
active cells
MemoryToNPRate Turns into Naive
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Table 5. Simulation parameters for different scenarios. The parameter c is only used in the first
scenario, where there is no proliferation. In the other scenarios, proliferation is defined by the equation(
1 + 300
N¯p
)
∗ 4.4
h
[3].
Scenario Description Parameters
λn λmn Np s b µNp c
1 No peripheral proliferation 0.22 0.05 387 0.48 3.4 0.13 0
2 No homeostatic reduction in thymic export, 2.1 0 713 0 0 4.4 –
no homeostatic alteration of naive death rate
3 Homeostatic alteration of naive death rate 0.003 0 392 0 4.2 4.4 –
but not thymic export
4 Homeostatic alteration of thymic export but 0.005 0 378 2.4 0 4.4 –
no naive death rate
5 No restrictions 0.005 0 378 2.2 0.13 4.4 –
Table 6. The data set used for validation obtained in [3] and [27]
Age
log
10
TREC
106×nPBMC number of individuals
0 5.03 48
1-4 4.93 53
5-9 4.86 19
10-14 4.86 19
15-19 4.56 33
20-24 3.88 26
25-29 3.75 47
30-34 3.61 65
35-39 3.54 73
40-44 3.52 52
45-49 3.37 55
50-54 3.17 16
Table 7. The data set collected in Lorenzi et al. [28]
Age log10 TREC106×nPBMC number of individuals
0 4.85 2
1-4 5.29 30
5-9 5.05 33
10-14 4.99 15
15-19 4.56 5
20-24 4.55 12
25-29 4.55 9
30-34 4.44 20
35-39 4.23 15
40-44 4.16 9
45-49 3.82 16
50-54 4.21 21
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Table 8. Wilcoxon test with 5% significance level comparing the results from SDMS and ABMS
Scenario p
1 0.8650
2 0.8750
3 0.7987
4 0.8408
5 0.9719
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